Skip to Main Content (Press Enter)

Logo CNR
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Strutture
  • Competenze

UNI-FIND
Logo CNR

|

UNI-FIND

cnr.it
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Strutture
  • Competenze
  1. Pubblicazioni

MELANOMA RESEARCH

Rivista
Codice:
E108401
ISSN:
0960-8931
  • Dati Generali

Dati Generali

Pubblicazioni (14)

  • ascendente
  • decrescente
Adjuvant therapy of melanoma: What's new?
Articolo
Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases
Articolo
Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign nevi, dysplastic nevi, and primary melanomas along with their metastases.
Articolo
Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign nevi, dysplastic nevi, primary melano-mas along with their metastases.
Articolo
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma
Articolo
Combined treatment with thymosin-alpha 1 and low-dose interferon-alpha after dacarbazine in advanced melanoma.
Articolo
Combined treatment with thymosin-alpha1 and low dose interferon-alpha after dacarbazine in advanced melanoma.
Articolo
Epiluminescence microscopy as useful approach in the early diagnosis of cutaneous malignant melanoma
Articolo
Identification of a 66 kD heat shock protein induced in Ml4 human melanoma cells by severe hyperthermic treatment.
Articolo
In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide.
Articolo
Mobile hospital rooms to fight melanoma
Articolo
Mutation analysis of candidate genes in melanoma-prone families: Evidence of different pathogenetic mechanisms at chromosome 9P21
Articolo
Recombinant interferon ?-2b and coenzyme Q10 as a postsurgical adjuvant therapy for melanoma: A 3-year trial with recombinant interferon-? and 5-year follow-up
Articolo
Recombinant interferon alpha-2b and coenzyme Q10 as a postsurgical adjuvant therapy for melanoma: a 3-year trial with recombinant interferon-alpha and 5-year follow-up
Articolo
No Results Found
  • «
  • ‹
  • {pageNumber}
  • ›
  • »
{startItem} - {endItem} di {itemsNumber}
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.1.0 | Sorgente dati: PREPROD (Ribaltamento disabilitato)